OncoloGIST, BioloGIST, RadioloGIST: the big impact on the field of oncology of a molecularly-targeted therapy designed to treat a rare disease

Author： Demetri G.D.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.39, Iss.14, 2003-09, pp. : 1976-1977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoneoadjuvant Therapy of Gastrointestinal Stromal Tumor (GIST)

By DeMatteo Ronald  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 799-800

Springer Publishing Company

Access to resources Recommend Favorite

GIST et sarcomes

By Cesne A.  

Oncologie, Vol. 9, Iss. 7-8, 2007-08 ,pp. : 525-534

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Therapy for Gastrointestinal Stromal Tumor (GIST): Racing Against Resistance

By Gold Jason   DeMatteo Ronald  

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1247-1248

Springer Publishing Company

Access to resources Recommend Favorite

The Effects of Surgical Cytoreduction Prior to Imatinib Therapy on the Prognosis of Patients with Advanced GIST

By An Ho   Ryu Min-Hee   Ryoo Baek-Yeol   Sohn Byeong   Kim Ki-Hun   Oh Sung   Yu Chang   Yook Jeong   Kim Byung   Kang Yoon-Koo  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4212-4218

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Surgery on Advanced Gastrointestinal Stromal Tumors (GIST) in the Imatinib Era

By Bonvalot S.   Eldweny H.   Péchoux C.   Vanel D.   Terrier P.   Cavalcanti A.   Robert C.   Lassau N.   Cesne A.  

Annals of Surgical Oncology, Vol. 13, Iss. 12, 2006-12 ,pp. : 1596-1603

Springer Publishing Company

Access to resources Recommend Favorite